The phrenotropic action of trilafon (perphenazine) in 323 neuropsychiatric patients.
D006801:Humans; D009497:Neurotic Disorders / Q000628:therapy*; D010546:Perphenazine; D010640:Phenothiazines / Q000031:analogs & derivatives; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000628:therapy*
D010640:Phenothiazines; D010546:Perphenazine; C031637:phenothiazine
NEUROSES/therapy; PHENOTHIAZINE/related compounds; PSYCHOSES/therapy